TYRA: tyra.bio Net earnings per share for the last 12 months

The rolling annual earnings per share value demonstrates the dynamics of Tyra Biosciences, Inc. (TYRA), which utilizes AI modeling for the automated selection of antitumor agents, with the parameter stabilizing at -2.64. The team consists of leading oncologists operating in a low-formality environment. Portfolio risks are minimized through selective FGFR inhibitors and the support of major investment funds.
Analytical breakdowns for Tyra Biosciences, Inc.

For precision oncology innovator Tyra Biosciences, Inc. (TYRA), this indicator reflects the monetization efficiency of its genetic mutation targeting developments via the ratio of total annual net income to the number of shares. By analyzing this 12-month net income per share chart, an investor can identify abnormal yield deviations, which is critical for assessing the fundamental value of a high-tech biopharmaceutical business.